Top 10 ophthalmic FDA approvals of 2018
8 monthes ago - By Healio
A host of new drugs and procedures entered the ophthalmic sphere in the past year with the FDA approving treatments for application in subspecialty areas of glaucoma, retina/vitreous, cornea/external disease, refractive surgery and cataract surgery.
Here are 10 of the most-read FDA approvals on Healio.com/OSN in 2018:
FDA approves Oxervate, the first drug to treat neurotrophic keratitis
Oxervate, cenegermin, developed by Dompé farmaceutici SpA, is the first FDA approved drug for the rare disease, which can cause loss of corneal sensation and impair corneal health.
Read more ...
The headlines of Master Doctor
Contraceptive Pills may Increase Type 2 Diabetes Risk
New study revealed that later puberty and menopause linked to lower type 2 diabetes risk, while contraceptive pill and longer time between periods linked to higher diabetes risk.
BRCA2 Gene Fault Ups Risk of Prostate Cancer
PSA tests were more likely to pick out more serious forms of prostate cancer in men who carry the BRCA2 gene fault than in non-carriers - suggesting these men could benefit...
Break Free From Menopause - Day 2: Thyroid Health
This is day two of break free from menopause. Today is all about thyroid health. Boosting our metabolism, getting some happier moods, making your hair more gorgeous and getting...
California's "holy herb" found to be an effective natural treatment for...
Alzheimer's disease is the most common form of dementia, and aging is its primary risk factor. Therefore, researchers continue to look for ways to counter the effects of aging...
New Study Explores Link Between Copper and Alzheimer's Disease
Studying copper regulation among normal and diseased cells could shed light on understanding the pathology of Alzheimer's disease and other neurodegenerative diseases, said...
Exercise May Delay Brain Deterioration in Risky People for Alzheimer's
New research from UT Southwestern shows less brain deterioration in physically active people at high risk for dementia.
Alzheimer's Treatment is Now a Step Closer
Important piece of the Alzheimer's puzzle has been found bringing us closer to a treatment for the illness.
Alzheimer's breakthrough as pioneering head device 'can REVERSE memory loss'
Researchers at private Arizona-based firm NeuroEM Therapeutics tested their transcranial electromagnetic treatment on a group of eight patients with mild or moderate Alzheimer's.
Existing Drug may Slow Progression of Parkinson's, Says Study
Drug used to treat enlarged prostate appears to improve Parkinson's symptoms in experimental models and human database analysis.
Targeted Radiotherapy Could cut Prostate Cancer Treatment Time
Advanced radiotherapy technique could help significantly reduce the treatment time for prostate cancer patients from two months to one or two weeks.